ArticleInternational journal of molecular sciences2021

EphB4 as a Novel Target for the EGFR-Independent Suppressive Effects of Osimertinib on Cell Cycle Progression in Non-Small Cell Lung Cancer.

Ren Nanamiya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.